A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.

Wang, Ena; Zhao, Yingdong; Monaco, Alessandro; Uccellini, Lorenzo; Kirkwood, John M; Spyropoulou-Vlachou, Maria; Panelli, Monica C; Marincola, Francesco M; Gogas, Helen

Wang, Ena; Zhao, Yingdong; Monaco, Alessandro; Uccellini, Lorenzo; Kirkwood, John M; Spyropoulou-Vlachou, Maria; Panelli, Monica C; Marincola, Francesco M; Gogas, Helen.

Affiliation

Wang E; Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, United States of America.

PLoS One ; 7(7): e40805, 2012.

Article in En | MEDLINE | ID: mdl-22911710

Subject(s)

Genetic Variation; Melanoma/genetics; Melanoma/mortality; Antineoplastic Agents/therapeutic use; CTLA-4 Antigen/genetics; Chemotherapy, Adjuvant; Forkhead Transcription Factors/genetics; Genotype; HLA Antigens/genetics; Humans; Interferon-alpha/therapeutic use; Melanoma/drug therapy; Melanoma/pathology; Models, Statistical; Neoplasm Staging; Polymorphism, Single Nucleotide; Prognosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Variation / Melanoma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google